New SEC Form D filing

Ansa Biotechnologies, Inc., 2026-11-18

A new SEC Form D private-offering notice from Emeryville, CA, a $71,903,290 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Ansa Biotechnologies, Inc. site↗ Verified via SEC Form D

Develops enzymatic DNA synthesis technology for producing complex, clonal DNA sequences and constructs

New filing yesterdayFiled to raise $71,903,290First money in 2026-10-16Raised so far $54,403,290HQ (as filed) Emeryville, CASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified ansabio.com↗Named in the filing 10 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source